テデュグルチド薬の世界市場2020-2026:ガテックス、リベスティブ

QYResearchが発行した調査報告書(QYR20AP02411)
◆英語タイトル:Global Teduglutide Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP02411
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月
◆ページ数:118
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥686,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,029,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,372,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、テデュグルチド薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、テデュグルチド薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(ガテックス、リベスティブ)、用途別市場規模(病院、薬局、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・テデュグルチド薬の種類別市場2015-2026:ガテックス、リベスティブ
・テデュグルチド薬の用途別市場2015-2026:病院、薬局、その他
・テデュグルチド薬の北米市場分析
・テデュグルチド薬のアジア市場分析
・テデュグルチド薬の中南米市場分析
・テデュグルチド薬の中東・アフリカ市場分析
・関連企業情報:Takeda Pharmaceuticals
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Teduglutide (brand names Gattex in the US and Revestive in Europe) is a 33-membered polypeptide and glucagon-like peptide-2 (GLP-2) analog that is used for the treatment of short bowel syndrome.In 2019, the global Teduglutide Drugs market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Teduglutide Drugs.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Teduglutide Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Teduglutide Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Teduglutide Drugs market. Readers of the report can become informed about current and future trends of the global Teduglutide Drugs market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Teduglutide Drugs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Teduglutide Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Teduglutide Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Teduglutide Drugs market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Teduglutide Drugs market is segmented into
Gattex
Revestive

Market Segment by Application, the Teduglutide Drugs market is segmented into
Hospital
Pharmacy
Other

This report includes the following manufacturers; we can also add the other companies as you want.
Takeda Pharmaceuticals

The study objectives are:
To analyze and research the global Teduglutide Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Teduglutide Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Teduglutide Drugs are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Teduglutide Drugs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Teduglutide Drugs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Gattex
1.3.3 Revestive
1.4 Market Segment by Application
1.4.1 Global Teduglutide Drugs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Teduglutide Drugs Revenue (2015-2026)
2.1.1 Global Teduglutide Drugs Revenue (2015-2026)
2.1.2 Global Teduglutide Drugs Sales (2015-2026)
2.2 Teduglutide Drugs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Teduglutide Drugs Sales by Regions (2015-2020)
2.2.2 Global Teduglutide Drugs Revenue by Regions (2015-2020)
2.3 Global Top Teduglutide Drugs Regions (Countries) Ranking by Market Size
2.4 Teduglutide Drugs Industry Trends
2.4.1 Teduglutide Drugs Market Top Trends
2.4.2 Market Drivers
2.4.3 Teduglutide Drugs Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Teduglutide Drugs Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Teduglutide Drugs Manufacturers by Sales (2015-2020)
3.1.1 Global Teduglutide Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Teduglutide Drugs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Teduglutide Drugs Sales in 2019
3.2 Global Top Manufacturers Teduglutide Drugs by Revenue
3.2.1 Global Teduglutide Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Teduglutide Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Teduglutide Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Teduglutide Drugs as of 2019)
3.4 Global Teduglutide Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Teduglutide Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Teduglutide Drugs Market
3.7 Key Manufacturers Teduglutide Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Teduglutide Drugs Historic Market Review by Type (2015-2020)
4.1.2 Global Teduglutide Drugs Sales Market Share by Type (2015-2020)
4.1.3 Global Teduglutide Drugs Revenue Market Share by Type (2015-2020)
4.1.4 Teduglutide Drugs Price by Type (2015-2020)
4.1 Global Teduglutide Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Teduglutide Drugs Sales Forecast by Type (2021-2026)
4.2.3 Global Teduglutide Drugs Revenue Forecast by Type (2021-2026)
4.2.4 Teduglutide Drugs Price Forecast by Type (2021-2026)

5 Global Teduglutide Drugs Market Size by Application
5.1 Global Teduglutide Drugs Historic Market Review by Application (2015-2020)
5.1.2 Global Teduglutide Drugs Sales Market Share by Application (2015-2020)
5.1.3 Global Teduglutide Drugs Revenue Market Share by Application (2015-2020)
5.1.4 Teduglutide Drugs Price by Application (2015-2020)
5.2 Global Teduglutide Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Teduglutide Drugs Sales Forecast by Application (2021-2026)
5.2.3 Global Teduglutide Drugs Revenue Forecast by Application (2021-2026)
5.2.4 Teduglutide Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Teduglutide Drugs Breakdown Data by Company
6.2 North America Teduglutide Drugs Breakdown Data by Type
6.3 North America Teduglutide Drugs Breakdown Data by Application
6.4 North America Teduglutide Drugs Breakdown Data by Countries
6.4.1 North America Teduglutide Drugs Sales by Countries
6.4.2 North America Teduglutide Drugs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Teduglutide Drugs Breakdown Data by Company
7.2 Europe Teduglutide Drugs Breakdown Data by Type
7.3 Europe Teduglutide Drugs Breakdown Data by Application
7.4 Europe Teduglutide Drugs Breakdown Data by Countries
7.4.1 Europe Teduglutide Drugs Sales by Countries
7.4.2 Europe Teduglutide Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Teduglutide Drugs Breakdown Data by Company
8.2 Asia Pacific Teduglutide Drugs Breakdown Data by Type
8.3 Asia Pacific Teduglutide Drugs Breakdown Data by Application
8.4 Asia Pacific Teduglutide Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Teduglutide Drugs Sales by Regions
8.4.2 Asia Pacific Teduglutide Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Teduglutide Drugs Breakdown Data by Company
9.2 Latin America Teduglutide Drugs Breakdown Data by Type
9.3 Latin America Teduglutide Drugs Breakdown Data by Application
9.4 Latin America Teduglutide Drugs Breakdown Data by Countries
9.4.1 Latin America Teduglutide Drugs Sales by Countries
9.4.2 Latin America Teduglutide Drugs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Teduglutide Drugs Breakdown Data by Type
10.2 Middle East and Africa Teduglutide Drugs Breakdown Data by Application
10.3 Middle East and Africa Teduglutide Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Teduglutide Drugs Sales by Countries
10.3.2 Middle East and Africa Teduglutide Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Takeda Pharmaceuticals
11.1.1 Takeda Pharmaceuticals Corporation Information
11.1.2 Takeda Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Takeda Pharmaceuticals Teduglutide Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Takeda Pharmaceuticals Teduglutide Drugs Products and Services
11.1.5 Takeda Pharmaceuticals SWOT Analysis
11.1.6 Takeda Pharmaceuticals Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Teduglutide Drugs Sales Channels
12.2.2 Teduglutide Drugs Distributors
12.3 Teduglutide Drugs Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Teduglutide Drugs Sales Forecast (2021-2026)
13.1.1 Global Teduglutide Drugs Sales Forecast by Regions (2021-2026)
13.1.2 Global Teduglutide Drugs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Teduglutide Drugs Sales Forecast (2021-2026)
13.2.2 North America Teduglutide Drugs Revenue Forecast (2021-2026)
13.2.3 North America Teduglutide Drugs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Teduglutide Drugs Sales Forecast (2021-2026)
13.3.2 Europe Teduglutide Drugs Revenue Forecast (2021-2026)
13.3.3 Europe Teduglutide Drugs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Teduglutide Drugs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Teduglutide Drugs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Teduglutide Drugs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Teduglutide Drugs Sales Forecast (2021-2026)
13.5.2 Latin America Teduglutide Drugs Revenue Forecast (2021-2026)
13.5.3 Latin America Teduglutide Drugs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Teduglutide Drugs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Teduglutide Drugs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Teduglutide Drugs Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Takeda Pharmaceuticals

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ テデュグルチド薬の世界市場2020-2026:ガテックス、リベスティブ(Global Teduglutide Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。